Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

XBRANE.ST SE Equity

Xbrane Biopharma AB
Nasdaq Stockholm+ CompareTear sheet →
Unclassified · FY ends Dec 31
SEK 9.98
+0.24 (+2.46%)
SEK · as of 2026-08-17 · marketstack

Legal & controls

No original 10-K is on record for this name in the filings index. Foreign filers (20-F / ESEF / EDINET) file no 10-K and therefore have no Item 3 or Item 9A to read.